Anuj Kumar

Thank you soooo much Shweta Chechi! Really happy to hear this from someone who I admire a lot! Beyond words😍

Hearty congratulations to our faculty @AnujkumarTvm for receiving a Travel Grant at the International Conference of Head and Neck Oncology (ICHNO) 2024, held in Busan, South Korea for an oral presentation "Impact of RT volumes on patterns of failure in oral cancers with PNI" 🎉🎓

Also happening now!! 'Chemo-Radiation Related Dysphagia Intervention: Pre-habilitation to Rehabilitation in Head and Neck Cancer' workshop @ACTREC_TMC

@learningonco @DrVijayPatil11 @pankajch37 @VanitaNoronha Around 50 % received Induction chemo during recurrence.

Hyperfractionation in Nasopharynx has OS advantage over standard fractionation. @AnujkumarTvm @pankajch37 @learningonco @VanitaNoronha thelancet.com/journals/lance…

@learningonco @DrVijayPatil11 @pankajch37 @VanitaNoronha True. 7 vs 24 %

@DrVijayPatil11 @pankajch37 @learningonco @VanitaNoronha Yes Sir. In unresectable recurrent nasopharyngeal cancers, results from this study are encouraging, showing an absolute 20 % improvement in 3 year OS Some caveats, for example late toxicities, may have been lower in the control arm if they used the 1.8 to 2 Gy/# rather than 2.2.

1/ The 1st AROI-ESTRO course on Head & Neck oncology has come to a successful close. 🎉 What an incredible event, bringing together experts and professionals in the field. @Sarbani28178063 @AnujkumarTvm @AshwiniBudrukar @shwetabhsinha23 @Samarpitaa_ @TataMemorial

The team ❣️

Glimpses of " Mastercourse in Head Neck and Breast Brachytherapy" conducted on 27th-29th April 2023 Cadaveric workshop in head neck brachytherapy at Nair Hospital @supriyasastri @RadOncTMC @RajivSarin5 @drtabassum1978 @RimaPathak1 @Samarpitaa_ @AnujkumarTvm @cspramesh

First screening in Bombay - well ok, in Thane & dear friends come from everywhere to cheer ! @driveAkar Salim @AnujkumarTvm Anupama @nnprem #PachuvumAlbhuthaVilakkum

Announcing the AROI - @ESTRO_RT Head & Neck training course 📢📢📢 ✅️ 25th - 27th May 2023 @TataMemorial ✅️ Focus on Oral Cavity & PNS tumors ✅️ For Rad Oncs & Med Physicists ✅️ Last date for registration 31st March 2023 ✅️ aroiestroheadneckcourse@gmail.com

Ph III RCT of 900 resected LA OSCC testing adjuvant treatment intensification with concurrent weekly cisplatin & accelerated RT. Only a cohort of patients with combination of high-risk features ( T3-4, N 2-3 & ECE+) likely candidates for intensification. Congratulations HN team!

Truly a wonderful picture. Of how someone with stage 4 lung cancer looks at life. Lessons for all of us. @Ravijharkhandi @IASLC @uicc @TataMemorial @CancerGridIndia

Vandana Gupta and the amazing team at @vcare24 have been planning to host a @chaiforcancer adda for a while now & how appropriate that it happened today along with the Diwali Puja at the V Care office . It is not just the thought followed up by this thoughtful action but the …

And then Dr @AnujkumarTvm says those magic words I Follow You On Twitter 🙏💙🙏

@supriyasastri Thanks a lot Madam

Here's some cheer to brighten your morning ☀️ Our own @AnujkumarTvm has won the Popular Choice Award for Male Voice at the *Doctor Sur Samrat Talent Hunt 2022* conducted by Lupin Pharma & hosted by @singer_shaan!! Congratulations Anuj! You deserve this and much more 🥳🎉🎊

Authors present impact of 1st wave of #COVID19 on RT practices @TataMemorial @ACTREC_TMC 4256 pts consulted @RadOncTMC between 1st Mar & 31st Oct 2020 Hypofractionation used across disease sites to minimize visits & optimize compliance Low rates of #COVID19 +vity during RT